Sansure Biotech Inc. (688289.SS) SHH

22.06

+0.03(+0.14%)

Updated at August 19 11:29AM

Currency In CNY

Sansure Biotech Inc.

Address

No. 680, Lusong Road

Changsha, 410205

China

Phone

86 731 8973 6948

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

2006

First IPO Date

August 28, 2020

Key Executives

NameTitlePayYear Born
Ms. Jun ZhouDeputy General Manager01971
Mr. Xialin YuDeputy GM & Director01979
Mr. Jia LiuDeputy GM & Director01982
Mr. Kai LiuDeputy General Manager01977
Mr. Haixiao WangDeputy General Manager01978
Mr. Qiang HuangSecretary01982
Mr. Zhongping DengDeputy General Manager01977
Ms. Xiaoyan XiongDeputy General Manager01983
Mr. Lizhong DaiChairman of the Board & GM01968
Mr. Zhu PengChief Financial Officer, Deputy GM & Director01975

Description

Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.